×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALVO – alvotech - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
01:58 pm
alvo
Alvotech (ALVO): A Bull Case Theory [Yahoo! Finance]
Low
Report
Alvotech (ALVO): A Bull Case Theory [Yahoo! Finance]
12/4
01:20 pm
alvo
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO
Low
Report
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO
12/3
08:04 am
alvo
Alvotech (NASDAQ:ALVO) was given a new $10.00 price target on by analysts at Morgan Stanley.
Low
Report
Alvotech (NASDAQ:ALVO) was given a new $10.00 price target on by analysts at Morgan Stanley.
12/2
08:10 pm
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/24
08:06 pm
alvo
Alvotech (ALVO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Regulatory Challenges [Yahoo! Finance]
Low
Report
Alvotech (ALVO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Regulatory Challenges [Yahoo! Finance]
11/24
12:43 pm
alvo
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
Low
Report
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman
11/24
05:30 am
alvo
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
Medium
Report
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area
11/22
07:56 am
alvo
Alvotech (NASDAQ:ALVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Alvotech (NASDAQ:ALVO) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/24
10:19 am
alvo
Form 6-K Alvotech For: Nov 24
Medium
Report
Form 6-K Alvotech For: Nov 24
11/20
07:45 am
alvo
Form 6-K Alvotech For: Nov 20
Medium
Report
Form 6-K Alvotech For: Nov 20
11/17
07:04 am
alvo
Form 6-K Alvotech For: Nov 12
Medium
Report
Form 6-K Alvotech For: Nov 12
10/22
08:00 am
alvo
Form 6-K Alvotech For: Oct 22
Medium
Report
Form 6-K Alvotech For: Oct 22
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: